Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia.
Au
Wing-Yan
WY
Kumana
Cyrus R
CR
Kou
Maybelle
M
Mak
Raymond
R
Chan
Godfrey C F
GC
Lam
Ching-Wan
CW
Kwong
Yok-Lam
YL
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010087:Oxides / Q000008:administration & dosage*; D012074:Remission Induction; D016879:Salvage Therapy; D016896:Treatment Outcome; D014212:Tretinoin / Q000627:therapeutic use
D001152:Arsenicals; D010087:Oxides; D014212:Tretinoin; D000077237:Arsenic Trioxide